GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Oncosil Medical OSL.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.66

-3.65%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Oncosil Medical — daily ASX:OSL

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Oncosil Medical on TradingView ↗
Market value
A$7.2m
Last close × shares
Volume
7.1k
Shares, 9 Nov 2026

About Oncosil Medical

Its shares trade on ASX under the ticker OSL.AX. It has been listed since 15 August 2005. In the fiscal year to 30 June 2026, it reported revenue of A$1.7m and a net loss of A$10.9m. At that date it held total assets of A$10.3m and shareholders' equity of A$5.0m.

OncoSil Medical Ltd. develops and commercializes neurology services, including those for pancreatic cancer. The company is headquartered in North Sydney, New South Wales. The company went IPO on 2005-08-15. The firm is engaged in the development of its lead product candidate, the OncoSil localized radiation therapy, for the treatment of pancreatic cancer. The firm's lead product, OncoSil, is a brachytherapy device that emits beta radiation and is implanted directly inside the cancerous tumor. OncoSil is a silicon and phosphorus (p32) beta emitter, able to be implanted intra-tumorally via endoscopic ultrasonography in localized solid tumors of patients with pancreatic cancer. The firm focuses on an application for Conformite Europeene (CE) Mark to enable commercial sales of OncoSil in the European Union and an application for an Investigational Device Exemption (IDE) from the United States Food and Drug Administration (FDA) to enable commencement of the United States pivotal clinical study, known as OncoPac-1.

Figures and description from our data supplier, not checked against the company's own report.

More about Oncosil Medical →

Latest on Oncosil Medical

Our reporting

We have not reported on Oncosil Medical yet.

Next results

2 Mar 2027

Due on 2 Mar 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Oncosil Medical's ticker?

Oncosil Medical trades as OSL.AX on ASX, under ISIN AU000000OSL3.

What was Oncosil Medical's last closing price?

0.66 on 9 Nov 2026. The figure is in AUD and is never converted.

When does Oncosil Medical next report results?

Results are expected on 2 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.